Related Experiment Video
Updated: Feb 4, 2026

Determining the Contribution of the Energy Systems During Exercise
Published on: March 20, 2012
Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors
Zane A Gibbs1, Angelique W Whitehurst1
1Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA; Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Tumors of nearly every origin activate the expression of genes normally restricted to gametogenic cells. These genes encode proteins termed cancer/testis (CT) antigens, since expression outside of their naturally immune-privileged site can evoke an immune response. Despite extensive efforts to exploit CT antigens as immunotherapeutic targets, investigation of whether these proteins participate in tumorigenic processes has lagged. Here, we discuss emerging evidence that demonstrates that CT antigens can confer a selective advantage to tumor cells by promoting oncogenic processes or permitting evasion of tumor-suppressive mechanisms. These advances indicate the inherent flexibility of tumor cell regulatory networks to engage aberrantly expressed proteins to promote neoplastic behaviors, which could ultimately present novel therapeutic entry points.
Insights
Cancer/testis (CT) antigens, normally found in gametes, are expressed in tumors. Emerging evidence shows these CT antigens promote cancer growth and immune evasion, offering new therapeutic targets.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumors frequently express genes normally restricted to gametogenic cells, producing cancer/testis (CT) antigens.
- Expression of CT antigens outside their immune-privileged site can trigger an immune response.
- The role of CT antigens in promoting tumor development has been understudied.
Purpose of the Study:
- To review emerging evidence on the role of CT antigens in tumorigenesis.
- To explore how CT antigens contribute to cancer progression and immune evasion.
- To identify potential therapeutic strategies targeting CT antigens.
Main Methods:
- Literature review of studies investigating CT antigen expression and function in cancer.
- Analysis of evidence linking CT antigen activity to oncogenic processes.
- Examination of mechanisms by which CT antigens facilitate immune evasion.
Main Results:
- CT antigens can provide a selective advantage to tumor cells.
- These antigens promote oncogenic pathways.
- CT antigens aid tumor cells in evading the host's immune system.
Conclusions:
- Aberrantly expressed CT antigens actively contribute to neoplastic behaviors.
- Tumor cells exploit CT antigens for growth and survival.
- Understanding CT antigen functions may reveal novel cancer therapeutic entry points.
Related Concept Videos
Emerging Adulthood
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Introduction Cardiac Emergencies
What is Behavior?
Applications of GIS: Disaster Management and Emergency Response

